The European Union's healthcare regulator on Wednesday said there currently is no evidence which links anti-inflammatory medicines such as ibuprofen with the worsening of COVID-19.
The EMA's announcement follows a similar tone on Monday from Nurofen producer Reckitt Benckiser to check reports that said the pills' active ingredient ibuprofen would hurt patients.